TransMedics Group Statistics
Total Valuation
TMDX has a market cap or net worth of $4.42 billion. The enterprise value is $4.54 billion.
| Market Cap | 4.42B |
| Enterprise Value | 4.54B |
Important Dates
The next confirmed earnings date is Wednesday, October 29, 2025, after market close.
| Earnings Date | Oct 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TMDX has 34.09 million shares outstanding. The number of shares has increased by 11.94% in one year.
| Current Share Class | 34.09M |
| Shares Outstanding | 34.09M |
| Shares Change (YoY) | +11.94% |
| Shares Change (QoQ) | +1.61% |
| Owned by Insiders (%) | 3.29% |
| Owned by Institutions (%) | 109.78% |
| Float | 32.95M |
Valuation Ratios
The trailing PE ratio is 64.28 and the forward PE ratio is 55.49. TMDX's PEG ratio is 1.11.
| PE Ratio | 64.28 |
| Forward PE | 55.49 |
| PS Ratio | 8.22 |
| Forward PS | 6.58 |
| PB Ratio | 13.88 |
| P/TBV Ratio | 14.88 |
| P/FCF Ratio | 254.83 |
| P/OCF Ratio | 38.36 |
| PEG Ratio | 1.11 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 45.26, with an EV/FCF ratio of 261.65.
| EV / Earnings | 63.35 |
| EV / Sales | 8.55 |
| EV / EBITDA | 45.26 |
| EV / EBIT | 59.29 |
| EV / FCF | 261.65 |
Financial Position
The company has a current ratio of 9.86, with a Debt / Equity ratio of 1.63.
| Current Ratio | 9.86 |
| Quick Ratio | 8.93 |
| Debt / Equity | 1.63 |
| Debt / EBITDA | 4.85 |
| Debt / FCF | 29.90 |
| Interest Coverage | 5.42 |
Financial Efficiency
Return on equity (ROE) is 28.21% and return on invested capital (ROIC) is 6.20%.
| Return on Equity (ROE) | 28.21% |
| Return on Assets (ROA) | 5.80% |
| Return on Invested Capital (ROIC) | 6.20% |
| Return on Capital Employed (ROCE) | 9.18% |
| Revenue Per Employee | $729,797 |
| Profits Per Employee | $98,437 |
| Employee Count | 728 |
| Asset Turnover | 0.64 |
| Inventory Turnover | 4.64 |
Taxes
In the past 12 months, TMDX has paid $2.43 million in taxes.
| Income Tax | 2.43M |
| Effective Tax Rate | 3.28% |
Stock Price Statistics
The stock price has increased by +3.63% in the last 52 weeks. The beta is 2.07, so TMDX's price volatility has been higher than the market average.
| Beta (5Y) | 2.07 |
| 52-Week Price Change | +3.63% |
| 50-Day Moving Average | 116.37 |
| 200-Day Moving Average | 101.79 |
| Relative Strength Index (RSI) | 65.20 |
| Average Volume (20 Days) | 879,905 |
Short Selling Information
The latest short interest is 7.97 million, so 23.38% of the outstanding shares have been sold short.
| Short Interest | 7.97M |
| Short Previous Month | 8.14M |
| Short % of Shares Out | 23.38% |
| Short % of Float | 24.19% |
| Short Ratio (days to cover) | 9.12 |
Income Statement
In the last 12 months, TMDX had revenue of $531.29 million and earned $71.66 million in profits. Earnings per share was $2.02.
| Revenue | 531.29M |
| Gross Profit | 317.68M |
| Operating Income | 76.58M |
| Pretax Income | 74.09M |
| Net Income | 71.66M |
| EBITDA | 100.30M |
| EBIT | 76.58M |
| Earnings Per Share (EPS) | $2.02 |
Balance Sheet
The company has $400.58 million in cash and $518.82 million in debt, giving a net cash position of -$118.25 million or -$3.47 per share.
| Cash & Cash Equivalents | 400.58M |
| Total Debt | 518.82M |
| Net Cash | -118.25M |
| Net Cash Per Share | -$3.47 |
| Equity (Book Value) | 318.10M |
| Book Value Per Share | 9.34 |
| Working Capital | 501.51M |
Cash Flow
In the last 12 months, operating cash flow was $115.27 million and capital expenditures -$97.92 million, giving a free cash flow of $17.35 million.
| Operating Cash Flow | 115.27M |
| Capital Expenditures | -97.92M |
| Free Cash Flow | 17.35M |
| FCF Per Share | $0.51 |
Margins
Gross margin is 59.79%, with operating and profit margins of 14.41% and 13.49%.
| Gross Margin | 59.79% |
| Operating Margin | 14.41% |
| Pretax Margin | 13.95% |
| Profit Margin | 13.49% |
| EBITDA Margin | 18.88% |
| EBIT Margin | 14.41% |
| FCF Margin | 3.27% |
Dividends & Yields
TMDX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.94% |
| Shareholder Yield | -11.94% |
| Earnings Yield | 1.62% |
| FCF Yield | 0.39% |
Analyst Forecast
The average price target for TMDX is $128.92, which is -0.61% lower than the current price. The consensus rating is "Buy".
| Price Target | $128.92 |
| Price Target Difference | -0.61% |
| Analyst Consensus | Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 21.04% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TMDX has an Altman Z-Score of 4.67 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.67 |
| Piotroski F-Score | 6 |